8-K
Current Report
InMed Pharmaceuticals Inc. Filed Acc 0001213900-26-024752
Exit or restructuring costs · Regulation FD disclosure
- Item 2.05 Costs associated with exit or disposal activities
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading ea0279869-8k_inmed.htm…